Cargando…
Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts
Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoic acid (RA) is the standard therapeutic agent for acute promyelocytic leukemia, but 10–20% of patients are not responsive, and initially responsive patients relapse and develop retinoic acid resistanc...
Autores principales: | Jensen, Holly A., Bunaciu, Rodica P., Ibabao, Christopher N., Myers, Rebecca, Varner, Jeffrey D., Yen, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055670/ https://www.ncbi.nlm.nih.gov/pubmed/24922062 http://dx.doi.org/10.1371/journal.pone.0098929 |
Ejemplares similares
-
An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program
por: Tasseff, Ryan, et al.
Publicado: (2017) -
6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
por: Bunaciu, Rodica P, et al.
Publicado: (2013) -
RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells
por: Wallace, Aaron S., et al.
Publicado: (2016) -
The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
por: Ibabao, Christopher N., et al.
Publicado: (2015) -
6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells
por: Bunaciu, Rodica P., et al.
Publicado: (2015)